DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

2.31 -0.05 (-2.12%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

KBIO $2.31 -2.12%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.35
Previous Close $2.36
Daily Range $2.24 - $2.41
52-Week Range $2.09 - $6.64
Market Cap $76.2M
P/E Ratio -1.34
Dividend (Yield) $0.00 (0.0%)
Volume 96,216
Average Daily Volume 215,464
Current FY EPS -$1.40

Sector

Industry

KaloBios Pharmaceuticals (KBIO) Description

Website: http://www.kalobios.com/

News & Commentary Rss Feed

KaloBios (KBIO) is now in Oversold Territory - Tale of the Tape

KaloBios (KBIO) is now in Oversold Territory - Tale of the Tape

How KaloBios (KBIO) Stock Stands Out in a Strong Industry - Tale of the Tape

How KaloBios (KBIO) Stock Stands Out in a Strong Industry - Tale of the Tape

KaloBios Initiates Phase 2 Expansion Portion of Study of KB004 in Hematologic Malignancies

KaloBios to Stop KB003 Development for Asthma - Analyst Blog

Stocks Hitting 52-Week Lows

Benzinga's Top #PreMarket Losers

KaloBios Reports Top-Line Data for Phase 2 Study of KB003 in Severe Asthma; Failed to Meet Primary E

KaloBios Reports Top-Line Data for Phase 2 Study of KB003 in Severe Asthma; Failed to Meet Primary Endpoint

KaloBios Pharmaceuticals: Undervalued Company With Huge Potential Catalyst

Preliminary Data from KaloBios' KB004 - Analyst Blog

Preliminary Data from KaloBios' KB004 - Analyst Blog

Actavis Cuts 350 Sales Positions in the U.S. - Analyst Blog

Actavis Cuts 350 Sales Positions in the U.S. - Analyst Blog

See More KBIO News...